June 24 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
FDA INVESTIGATING DEATHS DUE TO ACUTE LIVER FAILURE IN NON-AMBULATORY DUCHENNE MUSCULAR DYSTROPHY PATIENTS FOLLOWING ELEVIDYS
FDA: TWO REPORTED DEATHS IN NON-AMBULATORY DMD PATIENTS APPEAR TO BE RELATED TO TREATMENT WITH ELEVIDYS
Further company coverage: SRPT.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.